奥沙利铂联合氟尿嘧啶和亚叶酸钙治疗晚期胃肠癌的临床观察
奥沙利,,奥沙利铂;亚叶酸钙;氟尿嘧啶;联合化疗;晚期胃癌,大肠癌,1材料与方法,2结果,3讨论,参考文献
摘要:目的:评价国产奥沙利铂(L-OHP,艾恒)联合氟尿嘧啶(5-FU)和亚叶酸钙(CF)方案治疗晚期胃肠癌的近期疗效和毒性反应。方法:27例晚期胃肠癌,其中胃癌9例,大肠癌18例,初治8例,复治19例,化疗前均经肘正中静脉留置中心静脉导管。给予FOLFOX方案,即L-OHP130mg/m2,静脉滴注4h,d1;CF 200mg/m2,静脉滴注2h,d1,5-FU 500mg于CF滴完后静脉推注,续以5-FU2.4~3.0g/m2持续静脉滴注48h,每3周重复。按WHO标准评价近期疗效和毒性反应。结果:全组患者获得PR12(51.9%)例,其中胃癌的有效率为44.4%;大肠癌的有效率为55.6%,初治有效率62.5%,复治有效率47.4%,统计学处理无明显差异(P>0.05)。主要毒副反应为恶心呕吐(74.0%)、口腔黏膜炎和腹泻(59.2%),以及一过性感觉异常(55.6%)。结论:国产奥沙利铂联合CF/5-FU组成的FOLFOX方案治疗晚期胃肠道癌有效率较高,不良反应轻,值得进一步推广。关键词:奥沙利铂;亚叶酸钙;氟尿嘧啶;联合化疗;晚期胃癌/大肠癌
The Clinical Observation of Advanced Gastric Cancer and Colon Cancer Patients Treated with Oxaliplatin,Calcium folinate and 5-Fluorouracil combination chemotherapy
ZHANG Ai-ling,et al
(Nanhai west Oil Company Staff Hospital, Guangdong Zhanjiang 524057, China)
Abstract:Objective:To study the efficacy and toxicity of oxaliplatin(L-OHP)combined with calcium folinate(CF)and 5-fluorouracil(5-FU) in the treatment of advanced gastric/colon cancer.Methods:27 patients (9 cases gastric cancer,18 cases colon cancer) received chemotherapy of FOLFOX regimen:namely L-OHP130mg/m2 d1,continue injection (CI) for 4 hours;CF 200mg/m2 iv 2 hours d1,followed by 5-FU 500mg(bolus) and 5-FU 2.4-3.0g/m2 CI for 48hr with mini pump,q21d for 1 cycle.Results:The overall response rate was 51.9%,PR 14 cases,The response rate of gastric cancer and colon cancer was 44.4 % and 55.6% respectively.Significant difference was not observed between the two groups(p>0.05).The main side effects were nausea、vomiting(74.0%),mucositis and diarrhoea(59.2% ),The obvious side effect was sensory neuritis(55.6%),which was caused by L-OHP .Conclusion:L-OHP in combination with CF and 5-FU is an effective regimen in the treatment of advanced gastric/colon cancer,the toxicity is liable to be well tolerated. ......
您现在查看是摘要页,全文长 7666 字符。